Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children

Eastern Mediterranean Health Journal

Volumn 14, Issue 5, 2008, Pages 1028-1035

  Abd Al Aziz, A M ^a   Awad, M A M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADOLESCENT; ADULT; AGE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG INDICATION; EGYPT; FEMALE; HEALTH PROGRAM; HEPATITIS A; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SOCIAL CLASS; VACCINATION;

ADOLESCENT; AGE DISTRIBUTION; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; EGYPT; FEMALE; HEALTH PRIORITIES; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HUMANS; IMMUNITY, INNATE; MALE; NEEDS ASSESSMENT; POPULATION SURVEILLANCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; VACCINATION;

EID: 55149105640     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vitral CL, Gaspar AMC, Souto FJD. Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002: a review. Memorias do Instituto Oswaldo Cruz, 2006, 101(2):119-27.
2. Vitral CL et al. Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors. Memorias do Instituto Oswaldo Cruz, 1998, 93(1):1-5.
3. Wu J, Zou S, Giulivi A. Hepatitis A and its control. In: Viral hepatitis and emerging bloodborne pathogens in Canada. Canada communicable disease report, 2001, 27(S3).
4. Aggarwal R et al. Seroprevalence of anti-bodies to hepatitis A virus among children in Northern India. Indian pediatrics, 1999, 36:1248-50.
5. Bell BP. Hepatitis A vaccine. Pediatric infectious disease journal, 2000, 9:1187-8.
6. Duval B et al. Nationwide Canadian study of hepatitis A antibody prevalence among children eight to thirteen years old. Pediatric infectious disease journal, 2005, 24(6):514-9.
7. Prevention of hepatitis a through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and mortality weekly report, 2006, 55(RR07):1-23.
8. El-Zimiaty DM et al. Acute sporadic hepatitis in an Egyptian pediatric population. American journal of tropical medicine and hygiene, 1993, 48(3):372-6.
9. Darwish MA et al. High seroprevalence of hepatitis A, B, C and E viruses in residents in an Egyptian village in the Nile Delta, a pilot study. American journal of tropical medicine and hygiene, 1996, 54(6):554-8.
10. El-Zanaty F, Way AA. Egypt demographic and health survey 2000. Cairo, Egypt, Ministry of Health and Population; Calverton, Maryland, Macro International, 2001.
11. Salama I et al. Is there a change in the epidemiological pattern of hepatitis A in urban Egyptian children? Egyptian medical journal of the National Research Center, 2004, 15(7):163-78.
12. Fahmy SI, El-Sherbini AF. Determining simple parameters for social classification for health research. Bulletin of the High Institute of Public Health, 1983, 8(5):95-9.
13. Stroffolini T et al. Changing pattern of hepatitis A infection in children in Palermo, Italy. European journal of epidemiology, 1990, 6(1):84-7.
14. Afifi MS, Aly MF, Nooman Z. Serological markers of hepatitis A and B in Bedouin population of north Sinai, Egypt. Bulletin of Alexandria Faculty of Medicine, 1989, 25(3):781-7.
15. Al Rashed RS. Prevalence of hepatitis A virus among Saudi Arabian children: a community-based study. Annals of Saudi medicine, 1997, 17(2):200-3.
16. Turk Aribas E et al. Hepatitis A and hepatitis E prevalence of children in Konya/Turkey. Archives of gastroenterohepatology, 2000, 19:94-6.
17. Akbul A et al. The prevalence of hepatitis A in the Elazig region. Turkish journal of medical science, 1996, 26:375-8.
18. Ryskowska A et al. Prevalence of anti-HAV antibodies in a selected group of children. Przeglad epidemiologiczny, 2000, 54(3-4):375-83.
19. Hepatitis A virus seroprevalence in 1000 university students in Toronto. Canada communicable disease report, 2001, 27(11).
20. Chitambar SD et al. Prevalence of hepatitis A antibodies in western Indian population: changing pattern. Southeast Asian journal of tropical medicine and public health, 1999:30:273-6.
21. Sohn YM et al. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei medical journal, 2000, 41:31-9.
22. Svirtlih N. Epidemiology of hepatitis A and hepatitis E infections. Archives of gastroenteropathology, 2001, 20(1-2).
23. Dinelli MI, Fisberg M, Moraes-Pinto MI. Anti-hepatitis A virus frequency in adolescents at an outpatient clinic in Sao Paulo, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 2006, 48(1):43-4.
24. Hadjipanayis A et al. Prevalence of hepatitis A among children and adolescents in Lamaca, Cyprus. European journal of epidemiology, 1999, 15(10):903-5.
25. Hepatitis weekly [online] (http://www.newsrx.com/newsletters/ hepatitis-weekly, accessed 28 November 2007).
26. Das K et al. Is a vaccination program against hepatitis A needed in India? Indian journal of gastroenterology, 1998, 17:158.
27. Dhawan PS et al. Seroprevelance of hepatitis A virus in Mumbai and immunogenicity and safety of hepatitis A vaccine. Indian journal of gastroenterology, 1998, 17(1):16-8.
28. Junquera S et al. Studio seroepidemiologico de la hepatitis A en la comunidad de Madrid durante el ano 2002 [Seroepidemiologic study of hepatitis A in the community of Madrid during the year 2002]. Enfermedades infecciosas y microbiologia clinica, 2004, 22(8):448-51.
29. Abuzwaida AR et al. Seroepidemiology of hepatitis A and hepatitis B in two urban communities of Rio de Janeiro, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 1987, 24:219-23.
30. Vitral CL et al. Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors. Memorias do Instituto Oswaldo Cruz, 1998, 93(1):1-5.